SHARON JOHNSON: Open Payments
NPI 1497087894 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,839 in 140 payments from 29 companies in 2025. Trend: 2023 $3,540 · 2024 $2,446 · 2025 $3,839
Food & beverage: $3,839
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $712 |
| Eisai Inc. | 10 | $520 |
| UCB, Inc. | 14 | $491 |
| Neurocrine BioSciences, Inc. | 13 | $402 |
| Amgen Inc. | 7 | $282 |
| ARGENX US, INC. | 7 | $232 |
| TG Therapeutics, Inc. | 3 | $158 |
| Teva Pharmaceuticals USA, Inc. | 9 | $146 |
| Lilly USA, LLC | 2 | $138 |
| Merz Pharmaceuticals, LLC | 4 | $94 |
Products named: Leqembi, INGREZZA, QULIPTA, UPLIZNA, UBRELVY, Rystiggo, BRIUMVI, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
